ESPN insider David Schoenfield linked the Texas Rangers to free agent right-handed starting pitcher Tyler Mahle on Monday. Texas needs to improve its lineup and bullpen more than its rotation, but adding another starter would allow the Rangers to convert one of their current starters to a reliever, which would obviously bolster the bullpen.
While a healthy Mahle would make the Rangers a better team, there is one major reason why they likely wouldn't sign him, and another why they shouldn't. The Rangers likely wouldn't sign Mahle because he's too expensive; ESPN projects he will sign a three-year, $49.5 million contract this offseason.
Chris Young has made it clear he is doing everything he can to make the Rangers competitive next year on a payroll "very similar" to 2026, so it's hard to imagine they would shell out that much money to the right-hander. Of course, trading Corey Seager, Jacob deGrom, or Nathan Eovaldi could change things.
The Rangers would be making a mistake by signing Tyler Mahle
Even if the Rangers clear enough payroll space for Mahle, they shouldn't sign him given his injury history. Rangers fans know better than anyone that Mahle struggles to stay on the field. In his two seasons with Texas (2024-25), Mahle made just 19 starts. When healthy, he was great for the Rangers, posting a 2.54 ERA, but only 19 starts in two seasons is a major red flag.
Mahle signed a one-year contract with the San Francisco Giants this past offseason. He posted a rough 5.13 ERA over 18 starts with San Francisco before the Atlanta Braves acquired him at the deadline. He finished the season strong with Atlanta, posting a 1.99 ERA in nine regular-season starts and a 1.35 ERA across two postseason outings, which likely will earn him a big payday.
It's worth noting that right-handed starting pitcher Dustin May, who has also struggled with health in his career and is arguably a worse pitcher than Mahle, just signed a three-year, $52.5 million contract with the Chicago White Sox. Mahle is a few years older than May, but because Mahle had a better 2026 season, the former Ranger will likely sign a similar deal to May unless the whole league is worried about his injury history, which, honestly, they should be.
The other reason that this is complicated, even if the Rangers were willing to gamble on Mahle's health, is that they'd need to move at least one of the high-priced trio of aging stars they're shopping to make his contract fit. If Texas were to sign Mahle to replace either deGrom or Eovaldi due to a trade, they'd be gambling on a less-reliable option. If they traded Seager and used Mahle to upgrade over Jack Leiter or Kumar Rocker, it would be questionable whether the payoff is worth the effort.
Obviously, I wish Mahle the best of luck in free agency. He deserves to be paid well after finishing the season strong with the Braves. But he fits a big-market team that can handle losing top players to injuries for extended periods. Meanwhile, the Rangers must be careful with their limited budget.
